Vitamin D3 and Vitamin D3 Analogues as an Adjunct to Cancer Chemotherapy and Radiotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
683-690
Author(s):
David A. Gewirtz, Mona S. Gupta and Sujatha Sundaram
Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
715-726
Author(s):
Shintaro Abe and Makoto Otsuki
Receptor Tyrosine Kinases as Target for Anti-Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1959-1972
Author(s):
S. Brunelleschi, L. Penengo, M. M. Santoro and G. Gaudino
Cancer-Homing Toxins
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1973-1985
Author(s):
H. C. Ng and H. E. Khoo
Tumor Cell-Based Vaccination in Renal Cell Carcinoma: Rationale,Approaches, and Recent Clinical Development
Journal:
Current Drug Targets
Volume:
3
Page:
401-408
Author(s):
Johannes Volk, Saadettin Sel, Arnold Ganser and Patrick Schoffski
TGFb and its Smad Connection to Cancer
Journal:
Current Genomics
Volume:
3
Page:
449-476
Author(s):
S. Thiagalingam, K- h. Cheng, R. L. Foy, H. J. Lee, D. Chinnappan and J. F. Ponte
Biological Activities, Mechanisms of Action and Biomedical Prospect of the Antitumor Ether Phospholipid ET-18-OCH3 (Edelfosine), A Proapoptotic Agent in Tumor Cells
Journal:
Current Drug Metabolism
Volume:
3
Page:
491-525
Author(s):
Consuelo Gajate and Faustino Mollinedo
Diagnostic and Therapeutic Applications of Radiolabeled Somatostatin Analogs: Current Status in an Oncology Center
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1809-1814
Author(s):
Donald A. Podoloff
Anti-Cancer Drugs of Today and Tomorrow: Are we Close to Making the Turn from Treating to Curing Cancer?
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1723-1734
Author(s):
Shazib Pervaiz
Immune Modulation by Ionizing Radiation and its Implications for Cancer Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1765-1780
Author(s):
Eric J. Friedman